1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF407 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA TEAD2 CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA ZNF786 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA CYFIP2 CTRPv2 pan-cancer AAC 0.18 5e-06
mRNA SPDYE3 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA KCNN3 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA IRF4 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA IKZF3 CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA HDHD2 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA LIMD2 CTRPv2 pan-cancer AAC 0.18 0.0001
Download CSV